Medical device and MedTech insights, news, tips and more

HealthySole HOME Approved to Keep Your Home Safe From COVID-19

April 28, 2020


Researchers have proven a device using ultraviolet light technology can neutralize the COVID-19 virus and other infectious diseases on the soles of shoes by more than 99.5 percent, according to a new study. The device, called HealthySole® PLUS, is being introduced in hospitals and other settings where infection control is urgent. A home version of the device (HealthySole® HOME) is now available to you and your family.


“The device deactivated coronavirus markers by over 99.5 percent versus the control across three separate tests,” according to the report as published by CREM Co, an internationally recognized infectious disease research and testing organization based near Toronto, Canada.

With HealthySole HOME, you can kill those germs on the soles of your footwear.  Keeping viruses and bacteria out of your home reduces the risk of illness for you and your family.

Do you want to protect your family from COVID-19 and other infectious diseases with the HealthySole HOME?
Use the discount code LEGACY15 for 15% off at checkout!

Do you have a Frontline Hero you want to honor?

The HealthySole Team would like to honor our frontline heroes during this COVID19 pandemic.  We believe that all of our heroes are more than deserving of the utmost protection to keep themselves and their families safe during this challenging time — and especially when they return home from work.

HealthySole is donating one HealthySole® HOME unit each week through the end of June to a well-deserving frontline worker-hero. This HealthySole HOME unit can act as the first line of defense to kill or deactivate dangerous pathogens on the soles of their shoes before entering the home. This HealthySole HOME donation will help to keep our heroes and their families safe during this pandemic — and for years to come.

We need your help and nominations!

Please nominate the frontline worker-hero whom you think is a deserving candidate to be entered into the giveaway to receive a HealthySole HOME unit. There is no purchase necessary for a frontline worker-hero to be nominated nor to be chosen as the weekly winner!

Click here to nominate your healthcare hero!

HealthySole in Healthcare

As hospitals seek ways to reduce COVID-19 infections, a recent Center for Disease Control (CDC) report points out that the virus is spread through floors and foot traffic, and not just by person-to-person contact.

HealthySole_Commercial-Device (1)

“As people walk, they not only collect and spread pathogens on the soles of their shoes, but also aerosolize the virus, essentially kicking it back up in the air,” said HealthySole CEO Nelson Patterson. “The HealthySole device helps ensure pathogens aren’t tracked from patient rooms or wards to other locations. Preventing pathogen spread is critical for hospitals and other facilities, such as police stations with close quarters and high foot traffic, too.”

CDC Cites Wuhan on COVID-19 Spread in Hospitals

Research published April 10 by the CDC found that floors and shoe soles had the highest concentrations of COVID-19 in samples taken at a hospital facility in Wuhan, China. It also found the virus was being tracked well beyond patient rooms to other parts of the hospital, including into non-patient care areas such as hospital pharmacies where sampling indicated a 100 percent COVID-19 presence.

The study strongly recommended that “persons disinfect shoe soles before walking out of wards containing COVID-19 patients.”

While hospitals often scrub floors daily with a variety of cleaning agents, these steps provide only a temporary solution. As soon as someone walks on the cleaned floors with infected shoes, floors are rapidly re-contaminated, sometimes in as little as 30 minutes.

Prior research on one of the most difficult to control hospital pathogens, C. difficile, conducted at Children’s Hospital at Erlanger by the University of Tennessee College of Medicine at Chattanooga found UVC light exposure to shoe soles to be statistically beneficial with an overall average decrease of 28 percent for the number of positive swabs per room.

“These studies clearly show that infection prevention must move beyond the traditional single-minded focus on hand washing and reliance on personal protective equipment (PPEs),” Patterson said. “We have to look at our shoe soles – where we’ve been and where we’re going. Fortunately, UVC technology is offering a solution.”

About HealthySole

HealthySole provides the first published third-party clinically tested method to address shoes, a regularly ignored yet potent vector of germ transmission, including COVID-19, in hospital and other commercial settings, and even in homes.

How it works is simple. When a person stands on a HealthySole device, a steady beam of UVC light, the only wavelength of ultraviolet light known to kill germs, bathes the soles of their shoes. The entire process from start to finish takes only eight to 10 seconds. The device is immediately ready for the next person.

See Full Press Release: New Study Finds HealthySole UVC Technology Deactivates COVID-19 on Footwear

Written by: HealthySole

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.